Comparison of Interscalene Block and Suprascapular With Axillary Block

Shoulder Arthroplasty Clinical Trial

Official title:

Comparison of Analgesic Effectiveness of Ultrasound Guided Interscalene Block Versus Suprascapular With Axillary Block in Shoulder Arthroplasties

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04822610
• Other study ID #: 2020/1562
• Status: Completed
• Phase: N/A
• Start date: June 30, 2021
• Est. completion date: January 31, 2022

Study information

• Verified date: January 2022
• Source: Istanbul University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

In this study, the investigators are going to compare the analgesia effectiveness of interscalane block and suprascapular with axillary block in shoulder arthroplasties

Description:

In the preoperative period, the participants will be taken to the block room. The participants will be monitored, standard sedation will be applied.

The first group will be get interscalene block. The second group will be get suprascapular and axillary block. The third group patient will be get no block. Afterwards, the participants will be operated under general anesthesia. A patient-controlled analgesia device will be attached to each group of participants and their postoperative follow-up will be made.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 76
• Est. completion date: January 31, 2022
• Est. primary completion date: January 21, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 90 Years

Eligibility

Inclusion Criteria:

• accepting the study protocol,

• age older than 18 years and younger than 90 years,

• undergoing shoulder arthroplasty surgery

• the American Society of Anesthesiologist (ASA) physical status of I-II-III-IV

Exclusion Criteria:

• severe respiratory distress

• patients with local anesthetic allergy

• contralateral hemidiaphragmatic parrhesia

• recurrent laryngeal nerve palsy

• infection at the injection site

• coagulation disorder

Related Conditions & MeSH terms

• Shoulder Arthroplasty
• Ultrasound Guided

Intervention

Procedure:
• interscalene block
peripheral nerve block
• suprascapular block + axillary block
peripheral nerve block

Locations

Country	Name	City	State
Turkey	Istanbul University, Faculty of Medicine	Istanbul	Fatih

Sponsors (1)

Lead Sponsor	Collaborator
Istanbul University

Country where clinical trial is conducted

Turkey, 

References & Publications (4)

Cho N, Kang RS, McCartney CJL, Pawa A, Costache I, Rose P, Abdallah FW. Analgesic benefits and clinical role of the posterior suprascapular nerve block in shoulder surgery: a systematic review, meta-analysis and trial sequential analysis. Anaesthesia. 2020 Mar;75(3):386-394. doi: 10.1111/anae.14858. Epub 2019 Oct 3. — View Citation

Lee SM, Park SE, Nam YS, Han SH, Lee KJ, Kwon MJ, Ji JH, Choi SK, Park JS. Analgesic effectiveness of nerve block in shoulder arthroscopy: comparison between interscalene, suprascapular and axillary nerve blocks. Knee Surg Sports Traumatol Arthrosc. 2012 Dec;20(12):2573-8. doi: 10.1007/s00167-012-1950-5. Epub 2012 Mar 21. — View Citation

Park JY, Bang JY, Oh KS. Blind suprascapular and axillary nerve block for post-operative pain in arthroscopic rotator cuff surgery. Knee Surg Sports Traumatol Arthrosc. 2016 Dec;24(12):3877-3883. Epub 2016 Jan 5. — View Citation

Toma O, Persoons B, Pogatzki-Zahn E, Van de Velde M, Joshi GP; PROSPECT Working Group collaborators. PROSPECT guideline for rotator cuff repair surgery: systematic review and procedure-specific postoperative pain management recommendations. Anaesthesia. 2019 Oct;74(10):1320-1331. doi: 10.1111/anae.14796. Epub 2019 Aug 7. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Operation time	minutes	during surgery
Other	Hospital stay	days	postoperative period up to 3 days
Other	Postoperatif complication	yes-no	postoperative period up to 3 days
Other	Patient satisfaction	5-point Likert scale: very satisfied (= 5), relatively satisfied (= 4), fairly satisfied (= 3), relatively dissatisfied (= 2) and very dissatisfied (= 1)	postoperative period up to 3 days
Other	Beck Depression Inventory (BDI)	0-9: indicates minimal depression 10-18: indicates mild depression 19-29: indicates moderate depression 30-63: indicates severe depression.	Will be done 3 times 1- on pre-operative hospitalization 2- in the hospital after surgery 3- in the 1st month follow-up after surgery
Primary	Opioid (mg) consumption	Opioid (mg) consumption	48 hours
Primary	Measurement of postoperative pain	VAS (visual analog scale) (0: no pain, 10: the worst pain imaginable)	48 hours